{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:45:46Z","timestamp":1774917946250,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EV1-174804"],"award-info":[{"award-number":["EV1-174804"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"British Columbia Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209185","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:05:59Z","timestamp":1697774759000},"page":"209185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts"],"prefix":"10.1016","volume":"157","author":[{"given":"Jeanette","family":"Bowles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Werb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Bardwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209185_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107677","article-title":"Interactions of benzodiazepines with heroin: Respiratory depression, temperature effects, and behavior","volume":"158","author":"Afzal","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.josat.2023.209185_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/1609406919874596","article-title":"Using zoom videoconferencing for qualitative data collection: Perceptions and experiences of researchers and participants","volume":"18","author":"Archibald","year":"2019","journal-title":"International Journal of Qualitative Methods"},{"key":"10.1016\/j.josat.2023.209185_bb0020","article-title":"Relationships of prescription opioid sales to opiate treatment admissions and overdose deaths: A reanalysis of relationships \u2013 United States 2010-2019","author":"Aubry","year":"2022","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"Bao","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.josat.2023.209185_bb5010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.17269\/s41997-021-00504-9","article-title":"The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada","volume":"112","author":"Bardwell","year":"2021","journal-title":"Canadian Journal of Public Health"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00479-3","article-title":"Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs","volume":"18","author":"Bardwell","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-023-00525-2","article-title":"Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study","volume":"18","author":"Bardwell","year":"2023","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2023.209185_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108418","article-title":"Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada","volume":"130","author":"Bardwell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12954-022-00725-2","article-title":"The \u201cgoldfish bowl\u201d: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting","volume":"19","author":"Bardwell","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2023.209185_bb0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.17269\/s41997-021-00504-9","article-title":"The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada","volume":"112","author":"Bardwell","year":"2021","journal-title":"Canadian Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209185_bb0070","series-title":"Heroin compassion clubs","first-page":"1","author":"BCCSU","year":"2019"},{"issue":"10147","key":"10.1016\/j.josat.2023.209185_bb0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(18)31469-7","article-title":"The global health and equity imperative for safe consumption facilities","volume":"392","author":"Beletsky","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.josat.2023.209185_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: Prohibition\u2019s Iron Law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"902","key":"10.1016\/j.josat.2023.209185_bb0085","article-title":"Securing safe supply during COVID-19 and beyond","volume":"154","author":"Bonn","year":"2020","journal-title":"Scoping Review and Knowledge Mobilization DRAFT"},{"issue":"2","key":"10.1016\/j.josat.2023.209185_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1005574918294","article-title":"Disciplining addictions: The bio-politics of methadone and heroin in the United States","volume":"24","author":"Bourgois","year":"2000","journal-title":"Culture, Medicine and Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12954-021-00546-9","article-title":"Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: Clinical and social implications","volume":"18","author":"Bowles","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"S2","key":"10.1016\/j.josat.2023.209185_bb0100","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2105\/AJPH.2022.306776","article-title":"Mothers who use drugs: Closing the gaps in harm reduction response amidst the dual epidemics of overdose and violence in a Canadian urban setting","volume":"112","author":"Boyd","year":"2022","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209185_bb0105","series-title":"APA handbook of research methods in psychology, vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological","first-page":"57","article-title":"Thematic analysis","author":"Braun","year":"2012"},{"key":"10.1016\/j.josat.2023.209185_bb0110","series-title":"Opioid use disorder","author":"British Columbia Centre on Substance Use","year":"2022"},{"key":"10.1016\/j.josat.2023.209185_bb0130","series-title":"Drug checking service output","author":"Centre on Drug Policy Evaluation","year":"2020"},{"key":"10.1016\/j.josat.2023.209185_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: A rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209185_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102641","article-title":"Women\u2019s utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study","volume":"76","author":"Collins","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"34","key":"10.1016\/j.josat.2023.209185_bb0145","doi-asserted-by":"crossref","first-page":"E967 LP","DOI":"10.1503\/cmaj.200191","article-title":"Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada","volume":"192","author":"Crabtree","year":"2020","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1016\/j.josat.2023.209185_bb0150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0011000006287390","article-title":"Qualitative research designs: Selection and implementation","volume":"35","author":"Creswell","year":"2007","journal-title":"The Counseling Psychologist"},{"issue":"3","key":"10.1016\/j.josat.2023.209185_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209185_bb0160","article-title":"Spatial proximity and access to buprenorphine or methadone treatment for opioid use disorder in a sample of people misusing opioids in Southern California","volume":"108634","author":"Davidson","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/2158244014522633","article-title":"Qualitative content analysis: A focus on trustworthiness","volume":"4","author":"Elo","year":"2014","journal-title":"SAGE Open"},{"issue":"38","key":"10.1016\/j.josat.2023.209185_bb0175","doi-asserted-by":"crossref","first-page":"E1049","DOI":"10.1503\/cmaj.190344","article-title":"Injectable opioid agonist treatment for opioid use disorder: A national clinical guideline","volume":"191","author":"Fairbairn","year":"2019","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.42676","article-title":"Drug overdose mortality among people experiencing homelessness, 2003 to 2018","volume":"5","author":"Fine","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209185_bb0185","series-title":"Toxic drug crisis events and deaths and FNHA\u2019s response community situation report: January 2023 FNHA public health response","author":"First Nations Health Authority","year":"2023"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0740-5472(03)00031-X","article-title":"Long-term methadone maintenance effectiveness: Psychosocial and pharmacological variables","volume":"25","author":"Gerra","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"36","key":"10.1016\/j.josat.2023.209185_bb0195","doi-asserted-by":"crossref","first-page":"E1233 LP","DOI":"10.1503\/cmaj.220892","article-title":"Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario","volume":"194","author":"Gomes","year":"2022","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.josat.2023.209185_bb0200","author":"Government of Canada"},{"key":"10.1016\/j.josat.2023.209185_bb0205","series-title":"Wiley international encyclopedia of marketing","first-page":"2010","article-title":"Social desirability bias","volume":"1999","author":"Grimm","year":"2010"},{"key":"10.1016\/j.josat.2023.209185_bb0210","author":"Health Canada"},{"key":"10.1016\/j.josat.2023.209185_bb0215","author":"Health Canada"},{"key":"10.1016\/j.josat.2023.209185_bb0220","series-title":"Supporting people who use substances in shelter settings during the COVID-19 pandemic. Edmonton,. Edmonton, Alberta: Canadian Research Initiative in Substance Misuse; May 17, 2020","first-page":"1","volume":"1","author":"Hyshka","year":"2020"},{"key":"10.1016\/j.josat.2023.209185_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: The role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209185_bb0230","article-title":"\u201cIt\u2019s helped me a lot, just like to stay alive\u201d: a qualitative analysis of outcomes of a novel hydromorphone tablet distribution program in Vancouver, Canada","author":"Ivsins","year":"2020","journal-title":"Journal of Urban Health"},{"issue":"5","key":"10.1016\/j.josat.2023.209185_bb0235","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11524-022-00679-7","article-title":"Overdose prevention and housing: A qualitative study examining drug use, overdose risk, and access to safer supply in permanent supportive housing in Vancouver, Canada","volume":"99","author":"Ivsins","year":"2022","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada","volume":"15","author":"Karamouzian","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"19","key":"10.1016\/j.josat.2023.209185_bb0245","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0250","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13643-021-01764-9","article-title":"Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials","volume":"10","author":"Klimas","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1016\/j.josat.2023.209185_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209185_bb0260","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.9778\/cmajo.20150076","article-title":"Impact of a methadone maintenance program on an aboriginal community: a qualitative study","volume":"4","author":"Landry","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.josat.2023.209185_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108153","article-title":"COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings","volume":"119","author":"MacKinnon","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209185_bb0270","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13011-020-0253-y","article-title":"Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment","volume":"15","author":"Marchand","year":"2020","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209185_bb0280","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2023.209185_bb0290","series-title":"Medications to treat opioid use disorder","first-page":"1","author":"National Institute on Drug Abuse","year":"2018"},{"issue":"10","key":"10.1016\/j.josat.2023.209185_bb0295","doi-asserted-by":"crossref","first-page":"526","DOI":"10.12968\/ijtr.2009.16.10.44562","article-title":"Qualitative research: Part one \u2013 Philosophies","volume":"16","author":"Nicholls","year":"2009","journal-title":"International Journal of Therapy and Rehabilitation"},{"issue":"8","key":"10.1016\/j.josat.2023.209185_bb0305","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.josat.2023.209185_bb0310","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2023.209185_bb0315","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000631","article-title":"Physician communication in injectable opioid agonist treatment: Collecting patient ratings with the communication assessment tool","volume":"14","author":"Palis","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209185_bb0320","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","article-title":"Stigma at every turn: Health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb5000","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-021-00254-z","article-title":"CDC\u2019s efforts to quantify prescription opioid overdose deaths fall short","volume":"10","author":"Peppin","year":"2021","journal-title":"Pain and Therapy"},{"key":"10.1016\/j.josat.2023.209185_bb0325","doi-asserted-by":"crossref","unstructured":"Pijl, E. M., Alraja, A., Duff, E., Cooke, C., Dash, S., Nayak, N., Lamoureux, J., Poulin, G., Knight, E., & Fry, B. (2022). Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: An integrative review. In Substance abuse: Treatment, prevention, and policy (Vol. 17, (Issue 1)). BioMed Central Ltd. doi:https:\/\/doi.org\/10.1186\/s13011-022-00463-5.","DOI":"10.1186\/s13011-022-00463-5"},{"issue":"8","key":"10.1016\/j.josat.2023.209185_bb0330","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.14947","article-title":"The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada","volume":"115","author":"Piske","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209185_bb0340","series-title":"\u201cLockdown\u201d public health measures during the COVID-19 pandemic","first-page":"1","author":"Public Health Ontario","year":"2020"},{"key":"10.1016\/j.josat.2023.209185_bb0345","series-title":"NVivo","author":"QSR International Pty Ltd","year":"2020"},{"key":"10.1016\/j.josat.2023.209185_bb0350","series-title":"The British journal of general practice: The journal of the Royal College of general practitioners","first-page":"139","article-title":"The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence","volume":"Vol. 55","author":"Simoens","year":"2005"},{"key":"10.1016\/j.josat.2023.209185_bb0355","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","article-title":"Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006\u20132016","volume":"189","author":"Soc\u00edas","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"9737","key":"10.1016\/j.josat.2023.209185_bb0360","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","article-title":"HIV and risk environment for injecting drug users: The past, present, and future","volume":"376","author":"Strathdee","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2023.209185_bb0365","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2016.07.006","article-title":"Effectiveness of methadone maintenance therapy and improvement in quality of life following a decade of implementation","volume":"69","author":"Teoh Bing Fei","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209185_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102977","article-title":"Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada","volume":"91","author":"Thumath","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209185_bb0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/aje\/kwab129","article-title":"Time-series analysis of fentanyl concentration in the unregulated opioid drug supply in a Canadian setting","volume":"191","author":"Tobias","year":"2022","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1016\/j.josat.2023.209185_bb0380","doi-asserted-by":"crossref","DOI":"10.1097\/CXA.0000000000000089","article-title":"Xylazine identified in the unregulated drug supply in British Columbia, Canada","volume":"11","author":"Tobias","year":"2020","journal-title":"Canadian Journal of Addiction"},{"issue":"14","key":"10.1016\/j.josat.2023.209185_bb0385","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826084.2019.1653324","article-title":"Patient barriers and facilitators to medications for opioid use disorder in primary care","volume":"54","author":"Tofighi","year":"2019","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2023.209185_bb0390","series-title":"Demographics Duncan, British Columbia","author":"Townfolio","year":"2022"},{"key":"10.1016\/j.josat.2023.209185_bb0395","series-title":"Kamloops demographics, British Columbia","author":"Townfolio","year":"2022"},{"issue":"11","key":"10.1016\/j.josat.2023.209185_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Medicine"},{"issue":"8","key":"10.1016\/j.josat.2023.209185_bb0405","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/amajethics.2020.723","article-title":"Policy forum: How structural violence, prohibition, and stigma have paralyzed north american responses to opioid overdose","volume":"22","author":"Tyndall","year":"2020","journal-title":"AMA Journal of Ethics"},{"issue":"1","key":"10.1016\/j.josat.2023.209185_bb0410","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/joim.13478","article-title":"Advances in the omicron variant development","volume":"292","author":"Vitiello","year":"2022","journal-title":"Journal of Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209185_bb0420","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000887","article-title":"Supervised tablet injectable opioid agonist therapy (TiOAT): A strategy to address safer supply for individuals with an opioid use disorder?","volume":"16","author":"Weng","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209185_bb0425","series-title":"Opioid-overdose @ www.Who.Int","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.josat.2023.209185_bb0430","unstructured":"World Health Organization. (n.d.). Coronavirus disease (COVID-19) pandemic. 2021. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019?gclid=Cj0KCQjws4aKBhDPARIsAIWH0JXBeO1pE0oGpbXcNGvAvY1FKRz4BUYR84WxS95uPqFI9EcwnDg1MncaAggvEALw_wcB."},{"key":"10.1016\/j.josat.2023.209185_bb0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209185_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103601","article-title":"Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada","volume":"102","author":"Young","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209185_bb0445","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1353\/cpr.2020.0026","article-title":"Development of guidelines to improve the effectiveness of community advisory boards in health research","volume":"14","author":"Yuan","year":"2020","journal-title":"Progress in Community Health Partnerships: Research, Education, and Action"},{"key":"10.1016\/j.josat.2023.209185_bb0455","unstructured":"Zoom (Version: 5.11.6 (9890)). (n.d.). Zoom video communications."},{"issue":"6","key":"10.1016\/j.josat.2023.209185_bb0460","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000789","article-title":"Discontinuing methadone and buprenorphine: A review and clinical challenges","volume":"15","author":"Zweben","year":"2021","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:55Z","timestamp":1762652395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":82,"alternative-id":["S2949875923002369"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209185","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209185"}}